Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-31

FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application for Claritin LiQui-Gels (loratadine). The new liquid-filled gel capsule formulation expands the Claritin product line.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin Liqui-Gels (loratadine)

Snippet

SUPPL AP for CLARITIN LIQUI-GELS (LORATADINE)